Luiza Kanczuga-Koda
Overview
Explore the profile of Luiza Kanczuga-Koda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
827
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Szarpak L, Zaczynski A, Kosior D, Bialka S, Ladny J, Gilis-Malinowska N, et al.
Cardiol J
. 2020 Dec;
27(6):886-887.
PMID: 33346371
No abstract available.
2.
Szarpak L, Ruetzler K, Safiejko K, Hampel M, Pruc M, Kanczuga-Koda L, et al.
Am J Emerg Med
. 2020 Nov;
45:638-639.
PMID: 33246860
No abstract available.
3.
Jakubowska K, Koda M, Kisielewski W, Kanczuga-Koda L, Grudzinska M, Famulski W
Mol Clin Oncol
. 2020 Sep;
13(5):56.
PMID: 32905328
Colorectal cancer (CRC) is one of the most common malignant cancers worldwide. Patients with CRC are diagnosed based on various predictors, including performance status, clinicopathological factors and TNM classification. The...
4.
Jakubowska K, Koda M, Grudzinska M, Kanczuga-Koda L, Famulski W
World J Gastroenterol
. 2020 Sep;
26(31):4639-4655.
PMID: 32884222
Background: Colorectal cancer is the third most common malignancy worldwide. Therefore, it is critically important to identify new useful markers that can be easily obtained in routine practice. Inflammation is...
5.
Lomperta K, Jakubowska K, Grudzinska M, Kanczuga-Koda L, Wincewicz A, Surmacz E, et al.
World J Gastroenterol
. 2020 Aug;
26(28):4140-4150.
PMID: 32821075
Background: Despite effective prevention and screening methods, the incidence and mortality rates associated with colorectal cancer (CRC) are still high. Insulin receptor substrate 1 (IRS-1), a signaling molecule involved in...
6.
Kowalik A, Wincewicz A, Zieba S, Kopczynski J, Koda M, Sulkowski S, et al.
Folia Med (Plovdiv)
. 2020 Apr;
62(1):17-22.
PMID: 32337892
We examined a status of fibrosarcoma arising in dermatofibrosarcoma protuberans of 64-year-old male patient. A dermal, solid, grayish-yellow, desmin-negative trichrome-bluish tumor measured 1.5 cm in diameter pT1a (edition 8 pTNM)....
7.
Jakubowska K, Koda M, Kisielewski W, Kanczuga-Koda L, Famulski W
Exp Ther Med
. 2019 Dec;
18(6):4904-4912.
PMID: 31807155
The presence of tumor cells in the large intestine stimulates hypoxia and local inflammatory mediators that activate numerous inflammatory cells, including a diverse lymphoid tumor cell population. The aim of...
8.
Jakubowska K, Koda M, Kisielewski W, Kanczuga-Koda L, Famulski W
Oncol Lett
. 2019 Jul;
18(1):783-791.
PMID: 31289555
Cancer cells are characterized by a low antigenic immunogenicity, a rapid growth and an immunosuppressive effect on the extracellular matrix. These properties induce a weak immune response in colorectal cancer...
9.
Jarzabek K, Koda M, Chrusciel M, Kanczuga-Koda L, Sobczynska-Tomaszewska A, Rahman N, et al.
J Steroid Biochem Mol Biol
. 2019 Jul;
193:105420.
PMID: 31283987
Mutations in the X-linked androgen receptor (AR) gene cause complete androgen insensitivity syndrome (CAIS). CAIS may cause congenital sexual development disorder, which frequently develops into testicular tumors. Here, we describe...
10.
Jakubowska K, Kanczuga-Koda L, Kisielewski W, Koda M, Famulski W
Mol Clin Oncol
. 2018 Mar;
8(4):587-591.
PMID: 29556390
Squamous cell carcinoma (SqCC) of the breast should be differentiated between the primary skin keratinizing squamous carcinoma and squamous metaplastic cancer. In the current study, the cases of two patients...